LivaNova faces $360M liability after court ruling
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LivaNova PLC (LIVN)
LivaNova PLC stock price live, this page displays NASDAQ LIVN stock exchange data. View the LIVN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the LivaNova PLC real time stock price chart below.
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 41.88.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 41.88.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
41.88
-1.30(-3.01%)
Closed·
After Hours
42.71+0.84(+2.01%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.73
42.98
52 wk Range
32.48
61.94
LIVN Scorecard
Full Analysis
Net income is expected to grow this year
LIVN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.7342.98
52 wk Range
32.4861.94
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LIVN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
61.36
Upside
+46.52%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
7 analysts have revised their earnings downwards for the upcoming period
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro - LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro - LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- LivaNova faces $360M liability after court ruling
- Investing.com
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro - LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro
LivaNova PLC Company Profile
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
LivaNova PLC SWOT Analysis
Sleep Apnea Breakthrough | LivaNova's OSPREY trial reveals promising results for its Obstructive Sleep Apnea platform, potentially tapping into a large market by 2026 |
Depression Treatment Dilemma | Mixed results from the RECOVER trial for VNS Therapy in depression treatment prompt strategic reassessment, with future plans eagerly anticipated |
Financial Health Check | LivaNova maintains a strong financial position with revenue growth of 11% over 12 months and an "GREAT" financial health score from InvestingPro |
Market Valuation Insights | With a market cap of $2.88 billion and an analyst price target of $61.00, LivaNova's stock shows potential upside amid evolving growth strategies |
LivaNova PLC Earnings Call Summary for Q3/2024
- LivaNova reports 11% Q3 revenue growth, raises 2024 outlook to 8.5%-9.5% revenue growth and $3.30-$3.40 adjusted EPS
- Cardiopulmonary revenue up 15%, epilepsy revenue up 9%; Essenz heart-lung machine contributes 400 basis points to growth
- Adjusted operating income for ACS segment rises to $64M from $45M; adjusted free cash flow increases to $47M from $26M
- Company expects 10% manufacturing output increase from late 2023 to late 2024, aims for 100% Essenz system penetration in 3 years
- LivaNova anticipates margin growth to outpace revenue in 2025, with EPS growth projected above 20% for 2024
Last Updated: 31/10/2024, 10:32 pm
Read Full TranscriptCompare LIVN to Peers and Sector
Metrics to compare | LIVN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIVNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.3x | 21.5x | −0.4x | |
PEG Ratio | 0.02 | 0.12 | 0.00 | |
Price/Book | 2.2x | 2.9x | 2.6x | |
Price / LTM Sales | 1.8x | 4.8x | 2.9x | |
Upside (Analyst Target) | 43.3% | 56.3% | 51.7% | |
Fair Value Upside | Unlock | 5.5% | 9.5% | Unlock |
Analyst Ratings
9 Buy
2 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 61.36
(+46.52% Upside)
Earnings
Latest Release
May 07, 2025
EPS / Forecast
0.88 / 0.76
Revenue / Forecast
316.90M / 302.38M
People Also Watch
FAQ
What Is the LivaNova PLC (LIVN) Stock Price Today?
The LivaNova PLC stock price today is 41.88
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Is the LivaNova PLC Market Cap?
As of today, LivaNova PLC market cap is 2.28B.
What Is LivaNova PLC's Earnings Per Share (TTM)?
The LivaNova PLC EPS (TTM) is -4.09.
When Is the Next LivaNova PLC Earnings Date?
LivaNova PLC will release its next earnings report on 29 July 2025.
From a Technical Analysis Perspective, Is LIVN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has LivaNova PLC Stock Split?
LivaNova PLC has split 0 times.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.